These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 12126746
1. The mechanism of the angiotensin-converting enzyme inhibitor quinapril is not related to bradykinin level in heart tissue. Barthelemy C, Eurin J, Lechat P, Masson F, Cortines M, Mougenot N, Soualmia H, Carayon A. Peptides; 2002 Jun; 23(6):1161-9. PubMed ID: 12126746 [Abstract] [Full Text] [Related]
2. Acute and long-term dose-response study of quinapril on hormonal profile and tissue angiotensin-converting enzyme in Wistar rats. Schaison FH, Fernando Ramirez-Gil J, Ciferri S, Bernard M, Baudin B, Mougenot N, Carayon A, Lechat P. J Cardiovasc Pharmacol; 1996 Jul; 28(1):11-8. PubMed ID: 8797130 [Abstract] [Full Text] [Related]
3. Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system. Leenen FH, White R, Yuan B. Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2410-6. PubMed ID: 11709406 [Abstract] [Full Text] [Related]
4. Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects. Pellacani A, Brunner HR, Nussberger J. Clin Sci (Lond); 1994 Nov; 87(5):567-74. PubMed ID: 7874846 [Abstract] [Full Text] [Related]
6. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats. Hara K, Kobayashi N, Watanabe S, Tsubokou Y, Matsuoka H. Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177 [Abstract] [Full Text] [Related]
10. AT1 receptor blockade increases cardiac bradykinin via neutral endopeptidase after induction of myocardial infarction in rats. Walther T, Siems WE, Hauke D, Spillmann F, Dendorfer A, Krause W, Schultheiss HP, Tschöpe C. FASEB J; 2002 Aug; 16(10):1237-41. PubMed ID: 12153991 [Abstract] [Full Text] [Related]
11. ACE inhibitors and cardiac ACE mRNA in volume overload-induced cardiac hypertrophy. Lear W, Ruzicka M, Leenen FH. Am J Physiol; 1997 Aug; 273(2 Pt 2):H641-6. PubMed ID: 9277479 [Abstract] [Full Text] [Related]
12. Protective effect of quinaprilat, an active metabolite of quinapril, on Ca2+-overload induced by lysophosphatidylcholine in isolated rat cardiomyocytes. Ma H, Hashizume H, Hara A, Yazawa K, Abiko Y. Jpn J Pharmacol; 1999 Jan; 79(1):17-24. PubMed ID: 10082313 [Abstract] [Full Text] [Related]
13. Preservation of left ventricular mechanical function and energy metabolism in rats after myocardial infarction by the angiotensin-converting enzyme inhibitor quinapril. Horn M, Neubauer S, Frantz S, Hugel S, Hu K, Gaudron P, Schnackerz K, Ertl G. J Cardiovasc Pharmacol; 1996 Feb; 27(2):201-10. PubMed ID: 8720418 [Abstract] [Full Text] [Related]
14. Inhibition of aminopeptidase P potentiates wheal response to bradykinin in angiotensin-converting enzyme inhibitor-treated humans. Kim KS, Kumar S, Simmons WH, Brown NJ. J Pharmacol Exp Ther; 2000 Jan; 292(1):295-8. PubMed ID: 10604961 [Abstract] [Full Text] [Related]
15. Changes in cardiac ANG II postmyocardial infarction in rats: effects of nephrectomy and ACE inhibitors. Leenen FH, Skarda V, Yuan B, White R. Am J Physiol; 1999 Jan; 276(1):H317-25. PubMed ID: 9887046 [Abstract] [Full Text] [Related]